MAPT and Alzheimer disease: For example, 13 out 16 AD participants (81.3%) had an estimated Aβ effect favoring hyperexcitation –disregarding the magnitude–, 10 (62.5%) had hyperexcitable tau influences, and 9 (56.3%), Aβ·tau.